You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AVNS Disposition Disclosure
Galovan Scott Michael · SEC Form 4 · Filed Jul 28, 2026
Disposition
Reported value range
Not reported
Galovan Scott Michael SVP, Chief Financial Officer
AVNS
Avanos Medical
AVNS
Transaction date
Jul 27, 2026
Public filing date
Jul 28, 2026
Filing lag
Filed 1 day later
AVNS daily price context
Close on/before transaction
$24.99
Jul 27, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option (right to buy) on Common Stock
- Quantity / price
- 21,038 shares
- SEC ownership
- Direct
- Transaction code
- D
- Form
- 4
- Filing identifier
- 0001606498-26-000111
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$5.79M
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Avanos Medical, Inc. AVNS | Award | Jul 27, 2026 | $0 |
| Avanos Medical, Inc. AVNS | Disposition | Jul 27, 2026 | Not reported |
| Avanos Medical, Inc. AVNS | Disposition | Jul 27, 2026 | $2.4M |
| Avanos Medical, Inc. AVNS Current | Disposition | Jul 27, 2026 | Not reported |
| Avanos Medical, Inc. AVNS | Disposition | Jul 27, 2026 | $3.39M |